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ABSTRACT 
 
The number of people receiving mental illness diagnoses has increased in the last 
two decades.  As one of the most accessible healthcare professionals, pharmacists need to 
be prepared to assist in the management of patients with mental illness.  In this study, the 
objective was to see how pharmacists’ mental illness knowledge, acceptable social 
distance, familiarity, and perceived barriers may predict pharmacists’ attitude toward 
patients with mental illness and also their willingness to provide care to patients with 
mental illness.  The secondary objectives of this study were to test for differences in 
knowledge, attitude, perceived barriers, and willingness to provide care based on type of 
degree type of pharmacy, gender, and location.  This study utilized a descriptive, cross-
sectional survey design to collect study data from a sample of 196 pharmacists.  The 
respondents seemed to have an overall positive attitude towards patients with mental 
illness.  Nearly 60% of pharmacists reported that their pharmacy education adequately 
trained them to work with patients with mental illness.  In regard to education, 
pharmacists with a PharmD more strongly attributed physical symptoms to mental illness 
than did BSPharm-trained pharmacists.  Most of the pharmacists perceived time available 
for pharmacist to give attention to patients as one of the most significant barriers.  In 
terms of social distance, most pharmacists expressed that they would be willing to work 
alongside a person with mental illness than have same person as a babysitter for their 
child.  Although, pharmacists held a somewhat positive perception of patients’ mental 
illness, there was still a stigma assessed.  Due to this, there might be a need for 
 v 
educational interventions that will improve future pharmacists’ willingness to provide 
care to patients with mental illness.  
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BACKGROUND 
The Scope of Mental Illness 
 According to the National Alliance on Mental Illness, a mental illness is a 
condition that affects a person’s thinking, feeling, or mood.  Mental illness can be 
influenced by a variety of factors such as genetics, environment, and lifestyle.  The 
number of people receiving mental illness diagnoses has increased in the last two 
decades, as recent reports suggest that nearly 20% of Americans suffer from mental 
illness (National Institute of Mental Health, 2017).  In fact, according to the National 
Alliance on Mental Illness, approximately one in five adults in the United States 
experience some form of mental illness in a given year (National Institute of Mental 
Health, 2017). Similarly, one in five youth in the age category of 13-18 have experienced 
a severe mental disorder during their lifetime (National Institute of Mental Health, 2017).  
Young adults in the age category of 18-25 have the highest prevalence of mental illness 
(National Institute of Mental Health, 2017).  Mental illness affects the population as a 
whole and not just a specific age category.   
With increasing populations being diagnosed with mental illnesses each year, 
there has been an increase in access to health services to treat mental illness.  
Interestingly enough, only about 40% of adults with a mental illness received treatment in 
the past year (National Institute of Mental Health, 2017).  Additionally, only about 50% 
of children ages 8-15 with a mental illness received mental health services (National 
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Institute of Mental Health, 2017).  Lack of treatment has many negative consequences on 
individuals who suffer with mental illness, but it also has many consequences on greater 
society.  According to The American Journal of Psychiatry, mental illness costs America 
$193.2 billion in lost earnings per year.  There is an obvious need for better access to 
effective treatment for mental illness.   
The Pharmacist’s Role in Mental Illness 
Over the last decade, the pharmacist’s role in healthcare has evolved to a more 
patient-centered role.  Traditionally, a pharmacist’s key responsibilities were limited to 
managing the production and dispersion of medications.  As healthcare is continuously 
evolving, it is important that pharmacists use their extensive body of knowledge and 
skills to more effectively educate patients on their specific medications.  In a recent 
study, it was found that pharmacist-provided education leads to more positive health 
outcomes in chronically ill patients (Avalere Health, 2014).  In addition to the positive 
impact on the patient, pharmacist-provided education can also contribute to better health 
outcomes in the entire population (Avalere Health, 2014). 
In the United States, medication is a common treatment for a wide array of mental 
illnesses.  Given the prevalence of mental illness, pharmacists need to be prepared to 
assist in the management of these patients.  Accessibility to mental health services is 
currently a heavily debated topic.  There are many people in the United States who do not 
have access to quality mental health services.  Specifically, residents of rural 
geographical locations demonstrate a greater need for mental health services. These same 
residents were also recorded as having lower rural office-based mental health use and a 
much higher rate of prescription use. (Ziller EC, Anderson NJ, Coburn AF, 2010)  Even 
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in more populous geographical regions, there are many barriers to quality mental health 
services.  For instance, financial barriers can be a clearly defined problem when it comes 
to treating mental illness.  In addition, U.S. Department of Health and Human Services 
cites having a shortage of mental health professionals in the United States. (Department 
of Health and Human Services) As one of the most accessible healthcare professionals, 
pharmacists can significantly and positively affect the health outcomes of patients with 
mental illness. Previous studies have shown that when a pharmacist helped with 
monitoring antidepressant medication therapy, there were increased levels of patient 
adherence to the medication.  (Bultman DC, Syarstad BL. 2002)  But management of 
patients with mental illness requires more than just knowledge of the symptoms of mental 
illness and treatments, it requires a level of comfort and willingness to work with these 
patients.  
Literature Review of the Pharmacist’s Role in Mental Illness 
During the literature review process, we found there is not a substantial amount of 
literature that explored the community pharmacist’s role in a patient’s mental illness.  
There are several studies that have been conducted that do, however, study how attitudes 
toward mental illness patients affected pharmacists’ intentions to provide care to patients 
with mental illness.  (Cates, Burton & Woolley, 2005; Rickles, Dube, McCarter, & 
Olshan, 2011).  However, these studies were conducted with regional samples 
(pharmacists in Northeastern or Southeastern United States) and did not assess other 
factors that may influence willingness to provide care to patients with mental illness. 
In the first study, a survey was implemented to examine the attitudes of Alabama 
pharmacists towards patients who were diagnosed with mental illness.  The study found 
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that over 90% of the pharmacists disagreed with the statement that stated, “It is easy to 
recognize someone with mental illness.” Additionally, over 90% of the pharmacists in the 
sample disagreed with the statement that stated, “People with mental illness are not 
intelligent.” Most of the pharmacists also agreed “mental illness is nothing to be ashamed 
of.”  Overall, the study indicated that pharmacists expressed a somewhat positive attitude 
toward mental illness.  This particular study only used a regional sample of Alabama 
pharmacists and focused more on the attitudes of the mental illness instead of the 
attitudes on the pharmaceutical care of mental illness.  These could potentially limit the 
validity of the results as a national survey might give a larger, more representative data 
set.  (Cates, Burton & Woolley, 2005) 
In 2010, there was a study conducted that compared how community pharmacists 
perceived individuals with depression and schizophrenia and whether or not these 
attitudes affected their ability and/or willingness to provide services to these patients.  
Similarly to the previous study, the data collected from this study was also received from 
a regional sample (Northeastern United States).  In contrast, this study distinguished the 
difference between two particular mental illnesses (schizophrenia and depression).  Being 
more specific allowed the researchers to better understand if pharmacists might have 
differing attitudes on different mental illnesses.  Interestingly enough, the results showed 
that the pharmacists sampled seemed to have a more negative attitude towards patients 
with schizophrenia than those patients with depression.  The results also indicated that 
pharmacists would feel more comfortable treating a patient with asthma than a patient 
with a mental illness.  To reduce these negative attitudes, it is pertinent for educational 
interventions to take place that will allow pharmacists to more comfortably counsel 
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patients diagnosed with a specific mental illness.  In addition to reducing those negative 
attitudes, the study revealed it is important to increase the pharmacists’ perceived value 
of counseling their patients.   (Rickles, Dube, McCarter, & Olshan, 2011) 
 A study published by the University of Toronto in 2004 designed a questionnaire 
that encompassed pharmacist attitudes and barriers to providing adequate care for 
patients diagnosed with mental illness.  The study focused on how to eliminate the 
stigmatization given by healthcare providers (pharmacists) to their patients who use 
psychiatric medications.  The survey also indicated that pharmacists reported having 
generally positive attitudes towards patients who use psychiatric medications.  
Interestingly, the same pharmacists who demonstrated these positive attitudes also 
reported feeling more uncomfortable discussing mental illness with a patient than 
discussing cardiovascular disorders with a patient.  The study also indicated that many 
pharmacists perceived lack of adequate education on mental illness as a barrier to quality 
care.  The study also cited lack of privacy as a barrier to quality career.  Lack of privacy 
makes it difficult for pharmacists to provide quality patient counseling for patients with 
mental illness.  (Phokeo, Sproule, & Raman-Wilms, 2004) 
In a seemingly different approach, the College of Psychiatric and Neurologic 
Pharmacists (CPNP) and the National Alliance on Mental Illness (NAMI) collaborated on 
a study that surveyed a sample of individuals with a mental health condition.  Instead of 
studying the pharmacists’ attitudes, the researchers attempted to characterize the 
relationship between the patient and the pharmacist by examining the attitudes of 
individuals with mental illness.  One of the key findings from the study was that 91% of 
individuals taking medications for their illness feel comfortable visiting their community 
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pharmacist.  The survey approximated 25-30% of individuals with mental illness have 
seldom or rarely received information on their current medication from their pharmacist.  
Similar to other studies, one of the clear barriers to quality patient counseling in a 
pharmacy is lack of privacy.  This particular study mentioned that the individuals who 
participated in the survey viewed pharmacists as slightly disinterested in patient care 
because they seem to not have time for questions.  The study concludes that there is a 
great need to strengthen the role of a community pharmacist in mental health.  (Caley CF, 
Stimmel GL, 2012) 
In conclusion, there have been several studies that assessed the roles of a 
pharmacist in mental health.  However, a national survey sample may enhance the overall 
understanding of pharmacists’ attitudes toward patients diagnosed with mental illness.   
Study Objectives 
 
Due to the lack of studies that thoroughly examine multiple facets of pharmacists’ 
experience with mental illness in a national sample, the objectives of this study are to: 
1. Measure pharmacists’ mental illness knowledge;  
 
2. Measure pharmacists’ acceptable social distance from someone with a mental 
illness;  
 
3. Measure pharmacists’ familiarity with individuals with mental illness; 
 
4. Measure pharmacists’ attitude toward individuals with mental illness;  
 
5. Measure pharmacists’ perceived barriers to providing care to individuals with 
mental illness; and 
 
6. Measure pharmacists’ willingness to provide care to individuals with mental 
illness. 
 
The secondary objectives of this study were to test for differences in knowledge, 
attitude, perceived barriers, and willingness to provide care based on type of degree 
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(Bachelor’s Degree in Pharmacy versus Doctor of Pharmacy Degree), type of pharmacy 
(independent pharmacy versus retail chain pharmacy), gender (male or female), and 
location (rural or urban). 
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METHODS 
Design 
 
This study employed a descriptive, cross-sectional survey design to collect study 
data from pharmacists. Qualtrics was used as an electronic survey platform for 
pharmacists.  University of Mississippi IRB exemption was obtained before the study 
commenced. 
Sample & Data Collection 
 
We targeted a nationally representative convenience sample of 200 community 
pharmacists to meet study objectives.  Community pharmacists included pharmacists that 
work for independent pharmacies as well as retail chain pharmacies (such as Walmart, 
Walgreens, Kroger, CVS, Fred’s, Rite-Aid, etc.).  The goal was to obtain 100 pharmacists 
from each category. Pharmacists were recruited from Delta Marketing Dynamics 
(http://deltamarketingdynamics.com/).  The pharmacists were sent an email invitation to 
complete the survey, with a link survey included in the email. Pharmacists were 
continually recruited to participate until 196 responses were obtained. 
Measures 
 
 Demographic variables. Demographic variables collected in this study included 
1) gender, 2) age, 3) race/ethnicity, 4) practice site, 5) position, 6) years practicing, 7) 
year of graduation, 8) pharmacy degree, 9) state of practice, 10) rural/urban practice, 11) 
percentage of patients in practice with a mental health condition, 12) number of 
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continuing education programs in mental health completed in the last 5 years, and 13) 
perceived adequacy of education in mental health. 
 Mental illness knowledge. Following Swami, Persaud & Furnham (2011), 
pharmacists were asked to rate their lifetime knowledge of mental illnesses on a 7-point 
linear numeric scale where 1=not at all knowledgeable and 7=very knowledgeable. 
Mental illness familiarity. Familiarity was measured using a 12-item measure  
developed by Holmes, Corrigan, Williams, Conor, & Kubiak, 1999. Respondents were 
asked to check all situations on a list that they have experienced in their life. Their score 
on this measure was to be the most intimate situation indicated by the participant.  For 
example, as quoted by Holmes, “a person who checked ‘A friend of the family has a 
severe mental illness’ (rank order score = 9), ‘I have watched a documentary on 
television about mental illness’ (rank order score = 4), and ‘My job includes providing 
services to persons with a severe mental illness’ (rank order score = 7) would receive a 
score of 9 because ‘A friend of the family has a severe mental illness’ is the most 
intimate of checked situations.” 
Attitude toward individuals with mental illness. Attitude was measured with  
the Mental Illness: Clinician’s Attitude Scale (MICA-4) by Kassam, Glozier, Leese, 
Henderson C, Thornicroft G (2010) to assess respondents attitudes toward individuals 
with mental illness. This is a 16-item measure using a linear numeric scale where 
1=strongly disagree and 7=strongly agree. An example item reads, “People with severe 
mental illness are dangerous more often than not.” 
Acceptable social distance. Acceptable social distance was measured with the  
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Social Distance Scale (SDS) by Bell, Johns, & Chen (2006) whereby respondents 
indicated their willingness to associate with a person with a mental illness.  This scale is 
comprised of 7 items on 4-point linear numeric scales where 1=definitely willing and 
4=definitely unwilling.  Higher scores represent greater distance. An example item  
includes: Have one of your children marry that person. 
Perceived barriers. Perceived barriers were measured by combining and  
modifying two measures from pharmacy studies (Rickles, Dube, McCarter, & Olshan, 
2011; Scheerder, De Coster & Van Audenhove, 2008). The final measure is composed of 
11 items on a 5-point linear numeric scale where 1=very insignificant and 5=very  
significant. An example item includes: “Availability of a private counseling area in the 
pharmacy to discuss sensitive issues.” Because this measure was modified, it was 
successfully pretested among registered pharmacists in Mississippi. 
Willingness to provide care for mental illness patients. Willingness to provide 
care was measured with a scale used by Rickles, Dube, McCarter, & Olshan (2011) in a 
sample of pharmacists. It is a 9-item, 5-point linear numeric scale where 1=strong 
disagree, and 5-strongly agree.  An example item includes: “I would be willing to ask the 
patient questions about how the medication is helping his/her symptoms.” 
Analysis 
 
 Data was analyzed using IBM SPSS Statistics 25. The following procedures were 
utilized to analyze study data. 
 Sample description. The pharmacist sample was described by calculating 
frequencies, means, and percentages for the demographic characteristics of the 
pharmacist respondents. 
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 Mental health measures. Means and standard deviations were used to assess 
mental health measures including knowledge, social distance, familiarity, attitude, 
perceived barriers, and willingness to provide care.  
Differences testing. To meet the secondary objective of this study, Independent 
Samples t Tests were conducted at a .05 level of significance to test for differences in 
knowledge, attitude, perceived barriers, and willingness to provide care based on type of 
degree (Bachelor’s Degree in Pharmacy versus Doctor of Pharmacy Degree), type of 
pharmacy (independent pharmacy versus retail chain pharmacy), gender (male or 
female), and location (rural or urban). 
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RESULTS 
Sample Description 
 
 In order to better understand some of the characteristics of respondents, multiple 
demographic questions were assessed.  Of the 196 completed surveys, 109 (55.6%) were 
completed by males, and 87 (44.4%) were completed by females.  Participant ages ranged 
from 26 to 76 years of age, with an average age of about 46 years old (SD = 11.2).  On 
average, respondents had been practicing pharmacy for about 21 years (SD = 11.74). 
There was a large amount of variation as one respondent reported having practiced 
pharmacy for 49 years and one reported having practiced only one year.  In the overall 
sample, there was a relatively even distribution of respondents that worked in an 
independent pharmacy and respondents that worked in a large chain pharmacy (Table 1).  
Other participants in the survey recorded being employed by a Federally Qualified Health 
Center and a HMO Outpatient pharmacy. The majority of participants practice in an 
urban area (58.2%), while 41.8% of respondents practice in a rural setting.  The 
respondents also approximated that an average of 31% (SD = 18.46) of their patients are 
treated for some type of mental illness.  
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Table 1: Demographic Characteristics 
Nationality      
Number of Respondents 
(%) 
  African-America  2(1.0) 
     American Indian/Alaska Native 0 (0) 
     Asian/Asian Indian  22 (11.2) 
     Caucasian (white)  164 (83.7) 
     Hispanic    3 (1.5) 
     Native Hawaiian/Pacific Islander 0 (0) 
     Other     5 (2.6) 
Primary Area of Practice in Pharmacy Number of Respondents (%) 
Independent Pharmacy  96 (49.0) 
Large Chain Pharmacy  95 (48.5) 
Other     5 (2.55) 
Position in the Pharmacy   
Number of Respondents 
(%) 
Staff Pharmacist/ Relief Pharmacist/ Floater 
Pharmacist 79 (40.3) 
Pharmacy Manager/ Pharmacist in charge 101 (51.5) 
Regional Manager   15 (7.7) 
Pharmacy Owner   1 (0.5) 
Degrees Earned   
Number of Respondents 
(%) 
Bachelor of Science in Pharmacy (BSPharm) 110 ( 56.1) 
Doctor of Pharmacy (Pharm.D) 96 (49.0) 
Master of Science (MS)  1 (0.5) 
Doctor of Philosophy (PhD) 0 (0) 
Other     9 (4.6) 
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Mental Illness Knowledge 
 
Nearly 60% of respondents (59.2%) reported that their pharmacy education 
adequately trained them to work with patients with mental illness.  Additionally the 
respondents indicated their lifetime knowledge of mental illness was slightly above 
average on a scale from 1 to 7 where 1 = not at all knowledgeable and 7 = very 
knowledgeable (M = 4.56, SD = 1.04).   
There were no statistical differences when comparing pharmacists with a PharmD 
versus a BSPharm, independent pharmacists and retail chain pharmacists, or rural and 
urban pharmacists with regard to knowledge.  Males (M = 4.71; SD = 1.01) reported 
having more knowledge than females (M = 4.38; SD = 1.05) when it comes to mental 
illness (t = 2.21; p = 0.03) (Figure 1). 
 
Figure 1: Male and Female Reported Mental Illness Knowledge 
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Mental Illness Familiarity 
 
 Respondents were asked to indicate how familiar they were with mental illness by 
indicating “yes” or “no” to the items listed in Table 2. Five (5) pharmacists reported that 
they had never observed a person with a severe mental illness.  Four (4) pharmacist 
respondents reported actually having a severe mental illness. The highest frequency of 
respondents reported watching a movie or television show that depicted a character with 
a severe mental illness (n = 190).  Another high frequency of respondents (n = 174) had 
at least observed a person that had a severe mental illness.   
 
Table 2: Mental Illness Familiarity 
 Severity  Frequency  
I have never observed a person that I was aware had a 
severe mental illness. 1 5 
I have observed, in passing, a person I believe may have 
had a severe mental illness. 2 174 
I have watched a movie or television show in which a 
character depicted a person with mental illness. 3 190 
I have watched a documentary on the television about 
severe mental illness.  4 102 
I have observed persons with a severe mental illness on a 
frequent basis.  5 115 
I have worked with a person who had a severe mental 
illness at my place of employment. 6 54 
My job includes providing services to persons with a severe 
mental illness.  7 129 
My job involves providing services/treatment for persons 
with a severe mental illness.  8 142 
A friend of the family has a severe mental illness. 9 64 
I have a relative who has a severe mental illness. 10 64 
I live with a person who has a mental illness. 11 8 
I have a severe mental illness.  12 4 
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Attitude toward Individuals with Mental Illness 
 
On a scale from 1 to 5 where 1 = strongly disagree and 5 = strongly agree, 
respondents reported being just as comfortable talking to a patient with a mental illness as 
a patient with a physical illness (M = 3.83; SD = 1.00).  Respondents also agreed that 
mental health professions are just as respectable as other fields of health and social care 
(M = 4.35; SD = 0.84). Respondents generally disagreed that being a health/social care 
professional in the area of mental health is not like being a real health/social care 
professional (M = 1.70; SD = 0.92).  Respondents disagreed with using terms such as 
‘crazy’ or ‘nutter’ to describe people with mental illness that he/she might have seen at 
work (M = 1.75; SD = 0.93). Additional findings can be found in Table 3. 
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Table 3: Attitude toward Individuals with Mental Illness 
 Mean Standard Deviation 
I just learn about mental health when I have to, and would not 
bother reading additional material on it. 2.35 1.00 
People with a severe mental illness can never recover enough to 
have a good quality of life. 1.85 1.01 
Working in the mental health field is just as respectable as other 
fields of health and social care. 4.35 0.84 
If I had a mental illness, I would never admit this to my friends 
because I would fear being treated differently. 2.98 0.92 
People with a severe mental illness are dangerous more often than 
not. 2.43 0.88 
Health/social care staff know more about the lives of people treated 
for a mental illness than do family members or friends.  2.84 0.83 
If I had a mental illness, I would never admit this to my colleagues 
for fear of being treated differently.  3.14 0.95 
Being a health/social care professional in the area of mental health is 
not like being a real health/social care professional.   1.70 0.92 
If a senior colleague instructed me to treat people with a mental 
illness in a disrespectful manner, I would not follow their 
instructions. 
4.34 1.20 
I feel as comfortable talking to a person with a mental illness as I do 
talking to a person with a physical illness. 3.83 1.00 
It is important that any health/social care professional supporting a 
person with a mental illness also ensures that their physical health is 
assessed.   
4.37 0.72 
The public does not need to be protected from people with a severe 
mental illness.  2.71 0.96 
If a person with a mental illness complained of physical symptoms 
(such as chest pain) I would attribute it to their mental illness. 2.02 0.85 
General practitioners should not be expected to complete a thorough 
assessment for people with psychiatric symptoms because they can 
be referred to a psychiatrist.   
2.02 0.90 
I would use the terms ‘crazy’, ‘nutter’, ‘mad’ etc. to describe to 
colleagues people with a mental illness who I have seen in my work. 1.75 0.93 
If a colleague told me they had a mental illness, I would still want to 
work with them 3.90 0.81 
*1=strongly disagree to 5=strongly agree 
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Participants with a PharmD reported more agreement (M = 2.17; SD = 1.93) than 
those with a BSPharm (M = 1.88; SD = 0.74) that, “if a person with mental illness 
complained of physical symptoms (such as chest pain) I would attribute it to their mental 
illness” (t = -2.40; p = 0.02). Although both groups expressed low levels of agreement 
with the statement. There was no statistical differences found between independent and 
retail chain pharmacies with regard to attitude towards mental health.   
Females (M = 2.60; SD = 0.88) reported to agree more with the statement “people 
with a severe mental illness are dangerous more often than not” than their male (M = 
2.29; SD = 0.85) counterparts (t = -2.44; p = 0.02). 
Participants in the study who practice in urban areas (M = 3.11; SD = 0.85) more 
strongly agree with the statement, “If I had a mental illness, I would never admit this to 
my friends because I would fear being treated differently” than respondents practicing in 
rural areas (M = 2.80; SD = 0.99) (t = 2.29; p = 0.02). Similarly, participants in the study 
who practice in urban areas (M = 3.25; SD = 0.94) more strongly agreed with the 
statement that, “If I had a mental illness, I would never admit this to my colleagues for 
fear of being treated differently” than respondents practicing in rural areas (M = 2.98; SD 
= 0.94) (t = 2.05; p = 0.04). Participants who practiced in urban areas (M = 1.87; SD = 
1.04) were more likely to “use the terms ‘crazy’, ‘nutter’, ‘mad’, etc. to describe to 
colleagues people with a mental illness who I have seen in my work” than rural 
pharmacists (M = 1.59; SD = 0.72) (t = 2.12; p = 0.04).  
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Acceptable Social Distance 
 
 Where 1 = definitely willing and 4 = definitely unwilling, respondents were more 
willing to work alongside someone who was just hospitalized for a mental illness or have 
that person for a neighbor. Respondents were less willing to have that same person 
babysit their child or marry their child (Table 4). 
 
Table 4: Acceptable Social Distance 
 Mean Standard Deviation 
Share an apartment with that person 3.03 0.88 
Work alongside that person 2.12 0.85 
Have that person as a neighbor 1.97 0.87 
Have that person as a babysitter for your child 3.46 0.74 
Have one of your children marry that person 3.12 0.82 
Introduce to friend as relationship partner 2.82 0.92 
Recommend that person for a job 2.37 0.88 
* 1 = definitely willing to 4 = definitely unwilling 
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Perceived Barriers 
 
Respondents reported that time available for pharmacists to give individual 
attention to patients with mental illness as the most significant barrier (M = 4.01 where 1 
= a very insignificant barrier and 5 = a very significant barrier).  The least significant 
barrier appear to be support from pharmacy colleagues (M = 2.95) (Table 5). 
 
Table 5: Perceived Barriers 
 Mean Standard Deviation 
Pharmacy staff education in mental health and mental illness 3.40 1.01 
Pharmacist time available for individual attention to patients 4.01 1.05 
Access to information about patients and their treatment 3.76 1.04 
Availability of a private counseling area in the pharmacy to 
discuss personal issues 3.25 1.49 
Ability to communicate well with patients with mental illness 3.49 1.23 
Desire of patients with mental illness to receive care from their 
pharmacist 3.58 1.07 
Availability of support from management to provide services to 
patients with mental illness 3.18 1.30 
Access to training and resources on how to effectively educate 
and monitor patients receiving medications for their mental 
illness 
3.47 1.17 
Compensation for providing care to patients with a mental illness 3.34 1.33 
Support from the patient’s physician to perform services for 
patients with a mental illness 3.53 1.18 
Support for pharmacist colleagues to perform services for patients 
with a mental illness  2.95 1.21 
*1=very insignificant to 5= very significant 
 
Female participants (M = 3.56; SD = 0.99) perceived pharmacy staff education in 
mental health and mental illness as a more significant barrier to providing care to patients 
with mental illness than male participants (M = 3.28; SD = 1.01) (t = -2.01; p = 0.046) 
There was no statistically significant differences found between degree, type of practice, 
or location of practice. 
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Willingness to Provide Care for Mental Illness Patients 
 
Data collected to assess willingness to provide care for patients with mental 
illness did not demonstrate much variability. The highest mean level of agreement (4.53) 
showed that most respondents strongly agreed that he/she would be willing to ask the 
individual about adverse effects that the patient may be having with their specific 
medication. The lowest mean level of agreement (4.14) indicated that respondents also 
felt comfortable talking to an individual about his/her condition and medications.  
 
Table 6: Willingness to Provide Care for Mental Illness Patients 
 Mean Standard Deviation 
I would be willing to ask the individual questions about how the 
medication is helping his/her symptoms. 4.48 0.84 
I would be willing to ask the individual what his/her goals are in 
using the medication. 4.33 0.86 
I would be willing to ask the individual about adverse effects he/she 
may be having with the medication 4.53 0.83 
I would be willing to ask the individual questions about what he/she 
knows about the medication. 4.42 0.86 
I would be willing to ask the individual questions about how he/she is 
using the medication. 4.48 0.86 
I would be willing to help the individual solve any issues he/she was 
having with the medication.  4.48 0.83 
I would be willing to discuss any major concerns the patient was 
having with the medication with his/her physician. 4.43 0.84 
I would be willing to help the individual monitor his/her condition 
and help him/her identify any unmet goals of using the medication.   4.15 0.94 
I feel very comfortable talking to an individual about his/her 
condition and medications 4.14 0.99 
*1=strongly disagree to 5=strongly agree 
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There were no statistically significant differences found between degree types 
when it comes to willingness to provide care for patients with mental illness.  
Respondents who worked in independent pharmacies (M = 4.29; SD = 0.87) 
reported being more comfortable talking to a patient about his/her condition and 
medications than respondents who worked in retail chain pharmacies (M = 4.00; SD 
1.06) (t = 2.07; p = 0.04). 
Male respondents (M = 4.30; SD = 0.88) reported to feel more comfortable 
talking to a patient about condition and medications than female respondents (M = 3.93; 
SD = 1.09) (t = 2.65; p = 0.01). 
Respondents practicing in a rural area (M = 4.63; SD = 0.66) reported to be more 
willing to ask patients questions about how their medication is helping their symptoms 
than respondents who practice in an urban area (M = 4.37; SD = 0.93) (t = -2.21; p = 
0.03).   
Respondents who practice in rural areas (M = 4.51; SD = 0.72) reported to be 
more willing to ask the individual diagnosed with mental illness their goals in using their 
medication than respondents who practice in an urban area (M = 4.19; SD = 0.92) (t = -
2.61; p = 0.01).  
Respondents who practice in rural (M = 4.68; SD = 0.63) areas agreed more 
strongly with the statement, “I would be willing to ask the individual about adverse 
effects he/she may be having with the medication” than those respondents who practiced 
in urban areas (M = 4.42; SD = 0.93) (t = -2.21; p = 0.03).  
Respondents who practice in rural areas (M = 4.59; SD = 0.68) agreed more 
strongly with the statement, “I would be willing to ask the individual questions about 
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what he/she knows about the medication” than those who practice in urban areas (M = 
4.31; SD = 0.95) (t = -2.62; p = 0.03).   
Respondents who practice in rural areas (M = 4.62; SD = 0.70) reported that they 
would be more willing to help the patient solve any issues they were having with the 
medication relative to pharmacists practicing in urban areas (M = 4.38; SD = 0.90) (t = -
2.064; p = 0.04).    
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DISCUSSION 
 As mental illness diagnoses become more prevalent in the United States, the 
demand for more community pharmacists in mental healthcare is also increasing.  Recent 
studies have shown that a pharmacist can have a positive impact on a patient’s adherence 
to their medication for their particular mental illness. (Bultman DC, Syarstad BL. 2002) 
This increased adherence to medication can lead to positive health outcomes for 
individual patients diagnosed with mental illness. There are few studies on a community 
pharmacist’s role in community healthcare, and the few that are available are regional 
samples. The importance of this study indicates that a national survey sample will lead to 
an overall better understanding of pharmacists’ attitudes toward patients diagnosed with 
mental illness.  From this more representative sample, we may be able to better predict 
trends for community pharmacist’s role in mental healthcare.   
Interpretation of Results 
 Respondents approximated that around 31% of their patients in the community 
setting are being treated for some type of mental illness. This finding appears somewhat 
consistent with reports that 20% of Americans suffer from a mental illness (National 
Institute of Mental Health, 2017). It is not surprising that higher rates may be seen in the 
healthcare setting (in this case, a pharmacy) where patients are actually pursuing 
treatments for their illnesses.  
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Nearly 60% of pharmacists reported that their pharmacy education adequately 
trained them to work with patients with mental illness.  While this indicates that a little of 
over 40% of pharmacists felt that their education in mental illness was inadequate, it is 
important to consider that responses to this question could be a function of how long ago 
a respondent graduated.  Regardless, these finding may call for more emphasis on mental 
illness training for pharmacy students.  Indeed, the University of Mississippi School of 
Pharmacy, moving forward, will dedicate a course to central nervous system disorders 
and mental illness. 
Of those pharmacists responding, males reported having more knowledge than 
females when it comes to mental illness knowledge.  Whether this result is an actual 
representation of knowledge or a function of over-reporting, can be addressed in future 
research by administering an objective measure of mental illness knowledge, such as a 
quiz.  
 With regard to mental illness familiarity, most respondents reported lower 
severity ratings in terms of their familiarity with mental illness (i.e., watched a movie in 
which a character had a mental illness, etc.).  As expected, very few (n=5) reported never 
observing a person with a severe mental illness, and few reported living with a person 
with a mental illness (n=8) or having a severe mental illness themselves (n=5). These 
findings may be attributed to the difference in the terms “mental illness” and “severe 
mental illness” (see Table 2).   
Overall, pharmacists demonstrated a positive attitude toward individuals with 
mental illness.  This finding may be indicative of less stigmatization of mental illness 
(particularly as it relates to depression and anxiety) from a societal perspective. As with 
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any self-report survey, however, there is always risk of self-report bias. Future research in 
the area of mental illness attitude measure may mitigate this bias by having respondents 
answer on behalf of themselves and their colleagues as a means of comparison. 
Pharmacists with a PharmD more strongly attributed physical symptoms to mental 
illness than did BSPharm-trained pharmacists. While neither set of pharmacists felt 
strongly about this statement, it could be the greater emphasis in clinical training 
associated with the PharmD degree that resulted in this finding.  Female respondents 
more strongly agreed the statement “people with a severe mental illness are dangerous 
more often than not” than their male counterparts. Such a finding may be indicative of a 
greater perception of vulnerability among the female pharmacists as compared to the 
male pharmacists.  
  There were several statistically significant differences identified between 
pharmacists who practice in rural communities compared to pharmacists who practice in 
more urban communities.  Pharmacists in urban areas reported to be less willing to admit 
they had a mental illness to friends and colleagues, and were more likely to use slang 
terms to describe people with mental illness to their colleagues. Such findings may be 
indicative of a cultural difference between rural and urban settings, particularly as it 
relates to social norms and stigmas. 
 In terms of social distance, most pharmacists expressed that they would be willing 
to work alongside a person with mental illness, or have that person as a neighbor, but 
they would be unlikely to have that same person as a babysitter for their child or marry 
their child. Such findings are similar to those found in other studies using this measure, 
and being a pharmacist doesn’t appear to change these perceptions. 
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 There were many perceived barriers that respondents assessed as an obstacle to 
providing quality mental healthcare.  Most of the pharmacists perceived time available 
for pharmacist to give attention to patients as one of the most significant barriers.  This 
finding is consistent with other studies that cite time as one of the most significant 
barriers to providing patient services.  Our findings also suggest that access to 
information about patients and their particular treatment as a significant barrier.  
Pharmacy literature notes this to be a challenge for most patients, however.  
Female respondents reported staff education in mental health or mental illness as 
a more significant barrier than males did.  Perhaps this finding is due to perceptual 
differences between men and women with regard to available training in mental illness. 
 Not surprisingly, pharmacists indicated the strongest levels of agreement with 
items that outlined willingness to assist a patient with problems or issues specific to a 
medication they were taking. Also not surprisingly, they indicated their lowest level of 
agreement with the ideas of asking patients about their condition and medications and 
also willingness to monitor the patient’s condition for the purpose of meeting unmet 
medication goals. It is not surprising that pharmacists are comfortable dealing with 
medications for a patient with mental illness.  Perhaps pharmacists are less comfortable 
with an overall mental illness “condition” because they are less trained in the disease 
state of mental illness than they are in the medications that will treat the illness. It is also 
possible that some stigma was communicated in the word “condition”.  Future research 
will be needed to clarify why pharmacists were less willing to fulfill healthcare goals that 
included the word “condition”. 
 28 
Another finding suggested that respondents who worked in independent 
pharmacies reported feeling more comfortable talking to individuals about their condition 
and medication than respondents who worked in retail chain pharmacies.  This difference 
can be attributed to the close nature of the relationship between independent pharmacists 
and their patients.  The pharmacist at independent pharmacies typically know their 
patients better which could lead to an increased in willingness to provide care.   
Male respondents reported to be more at east talking to individuals about their 
condition and medication than female.  Perhaps this finding is related to the earlier 
finding that female respondents were more likely to perceive mental illness patients as 
dangerous than did male respondents. 
 There were several statistically significant differences found between rural 
pharmacists and urban pharmacists in regard to their willingness to provide care for 
mental illness patients.  Respondents practicing in rural communities were generally 
more willing to consult with mental illness patients on the medicines they were using to 
treat their conditions.  This can possibly attributed to the small-town effect of living in a 
rural community where the pharmacists might know more of his or her patients, 
therefore, feeling more willing to provide care by asking these questions.  It could also be 
attributed to the fact that urban pharmacies might have a higher prescription volume and 
therefore be busier and not have as much time to address these specific concerns by 
asking these questions.   
Limitations 
 
Given the topic of this research, social desirability emerges as one of the most 
significant limitations to the findings of this study. It is very possible that although 
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respondents were anonymous to the study investigators, that there still was risk in 
responding more positively. Some studies have addressed this limitation by having 
respondents respond on behalf of themselves and their colleagues, therefore offering 
some type of comparison by which to assess social desirability bias. However, a balance 
between risk of social desirability bias and respondent burden must be considered 
especially for more complex survey items. 
Future Research 
 
 Future research should expand on the work done on this study by evaluating how 
pharmacists’ mental illness knowledge, acceptable social distance, familiarity, and 
perceived barriers may predict pharmacists’ attitude toward patients with mental illness 
and also their willingness to provide care to patients with mental illness.  Additionally, 
measuring these variables in a pharmacy student population may provide earlier insight 
into attitudes on mental illness from future pharmacists, when educational interventions 
can still be made.  
Study Implications 
 While pharmacists had a somewhat positive perception of patients with mental 
illness, findings still corroborate existing literature that some stigma exists with mental 
illness when compared to other conditions like diabetes or asthma. This, combined with a 
large number of respondents who indicate inadequate preparation for pharmacy practice 
in mental illness, suggest educational interventions in the form of modular learning 
approaches, active learning, service learning, skills labs, problem-based learning, and 
experiential education may be important to improve future pharmacists comfort level and 
expertise in mental illness 
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